In the first opportunity for industry watchers to compare the two approved TROP2 antibody-drug conjugates side by side in ...
Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and ...
GSK may be happy with the latest readouts from two Hansoh-partnered antibody-drug conjugates (ADCs), but the Big Pharma’s ...
From October 17 to 21, the European Society for Medical Oncology (ESMO) Annual Congress convened in Berlin, bringing together global leaders in oncology ...
Singapore-based pharmaceutical companies are seeking clarity on tariff exemptions amid new US tariffs, impacting billions in ...
HYDERABAD: Noting that India ranks third globally in pharmaceutical supply by volume but only 14th by value, Dr N Madhusudhan ...
Biopharma data showed M&A strength, selective venture capital favoring Phase II, record obesity deals, and significant ...
From October 17 to 21, the European Society for Medical Oncology (ESMO) Annual Congress convened in Berlin, bringing together global leaders in oncology and pharmaceutical innovation. Representing ...
XPH offers diversified exposure to large-, mid-, and small-cap pharma stocks, balancing blue-chip stalwarts and speculative ...
BW Pharma Awards 2025 recognizes India’s pharmaceutical innovators driving excellence, ethics, and transformation in global ...
In today’s Pharmaceutical Executive Daily, we cover Takeda’s new multi-year research collaboration with Nabla Bio, how tariff ...
Learn how FTIR spectroscopy simplifies pharmaceutical formulation by providing rapid, accurate molecular analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback